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Abstract 
During an observed simulation clinical exam, a patient presented to the clinic with severe 
osteoarthritis in bilateral knees. A preoperative consultation was done at this time prior to a 
scheduled right total knee arthroplasty in Fargo, ND on 3/4/2020. A left total knee arthroplasty 
was performed less than 1 year ago and now the right knee has been worsening since that time. 
Preoperative lab work drawn today revealed a fasting blood glucose of 229 mg/dL and a HbA1C 
of 7.9%.  
A literature review was performed to explore the optimal HbA1C prior to orthopedic 
surgery and how intraoperative and postoperative blood glucose can affect outcomes. It is 
already known that poorly controlled diabetes with hyperglycemia is directly related to poor 
wound healing and infections. This review will discuss what HbA1C is optimal prior to 
proceeding with an orthopedic procedure and how uncontrolled blood glucose can cause 
complications postoperatively.  
The literature review revealed: a HbA1c level <7% is associated with less complications, 
a fasting blood glucose level of < 200mg/dL is associated with less complications, and a HbA1c 
level < 8% may be acceptable in some patients after shared-decision making has been done 
between patient and provider. This data in research can help determine the postoperative risk 
associated with a total knee arthroplasty. All patients and providers should strive for optimal 
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Optimal HbA1c in Orthopedic Surgery 
Background 
Poorly controlled diabetes is directly associated with poor wound healing and many types 
of infections. When discussing poor outcomes, Carey et al. (2018) report that it’s well known 
that diabetes and infections are associated clinically in several ways including impaired immune 
response, a hyperglycemic environment, neuropathy, and altered lipid metabolism.  
This review discusses a 57-year-old female who was seen in the primary care provider’s 
(PCP) office for a preoperative evaluation. She is scheduled the following week to have a right 
total knee arthroplasty done in Fargo, ND. She has a past medical history of poorly controlled 
type 2 diabetes mellitus and is prescribed several diabetes medications but reports that she’s not 
been taking them as prescribed. She had preoperative lab work done for the visit today which 
revealed a fasting blood glucose of 229 mg/dL and a HbA1C of 7.9%. She reports that she “very 
rarely” checks her blood glucose at home.  
The purpose of this review is to investigate current best practice and define what is 
considered an optimal preoperative HbA1C level. This review will also discuss how 
intraoperative and postoperative blood glucose management can cause complications in the 
postoperative setting. During the perioperative and postoperative phase, many type 2 diabetic 
patients will need insulin to manage blood glucose, even if they have not used these medications 
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Case Report 
Assessment / Plan 
Preoperative evaluation for a right total knee arthroplasty 
 
Plan: high risk for orthopedic surgery. Further cardiopulmonary testing (stress testing) is not 
needed at this time but will order EKG, CBC, CMP, HbA1C and discuss results with patient.   
We discussed that she is currently taking excess NSAIDS when combining Motrin and voltaren, 
especially with her CKD. She should not take both medications together. Also discussed that she 
should stop NSAIDs and all supplements at least 1 week prior to the procedure and hold 
metformin about 48 hours prior to procedure. We discussed that she should start using the 
Victoza as prescribed and if further teaching is needed, we can provide that. Discussed that she 
may need to start insulin if diabetes remains uncontrolled. Discussed that it is very important to 
begin checking blood sugars at least 1-2 times a day to trend blood glucose levels. Due to 
multiple chronic comorbidities, she is at high risk for intraoperative and postoperative 
complications. She does verbalize understanding and wishes to proceed. She can proceed 
pending results of ordered labs/EKG and approval from surgeon.  
She should follow up prior to surgery if symptoms worsen or new symptoms develop. She is an 




Patient presents for a preoperative consultation regarding upcoming right total knee arthroplasty 
in Fargo, ND on 3/4/2020. She had a left total knee arthroplasty less than 1 year ago and now 
reports that her right knee has been worsening over the last year or so. The pain in the right knee 
is constant and feels like sharp, grinding pain. Weight-bearing and exercise makes the pain worse 
and resting and taking NSAIDs makes the pain slightly better. Pain seems worse in the morning 
but also does seem to be constant throughout the day. Rates the pain 7/10 in severity. Has 
attempted treatment with NSAIDs but is unable to exercise/lose weight due to the pain.  
 
Allergies: seasonal allergies – reaction: rhinorrhea  
 
Medications 
diclofenac sodium (VOLTAREN) Take 1 tablet (75 mg) by mouth 2 times a day  
 liraglutide (VICTOZA) Inject 1.8 mg subcutaneously 1 time per day 
fluticasone (FLONASE) 50 mcg/spray nasal spray 1 spray into each nostril 1 time per day 
insulin needle (BD PEN NEEDLE NANO U/F) 32G X 4 mm Use once daily as directed 
metFORMIN (GLUCOPHAGE XR) 1000 mg extended release tablet twice a day 
acetaminophen (TYLENOL) 500 mg tablet Take 1,000 mg by mouth Every 4 hours as needed 
vitamin C, ascorbic acid, 500 MG tablet Take 1,000 mg by mouth 1 time per day 
milk thistle-turmeric (SILYMARIN) CAPS capsule Take 1 capsule by mouth 1 time per day 
glipiZIDE ER (GLIPIZIDE XL) Take 1 tablet (10 mg) by mouth 1 time per day 
hydroCHLOROthiazide 25 mg tablet Take 1 tablet (25 mg) by mouth 1 time per day 90 
lovastatin (MEVACOR) 10 mg tablet Take 1 tablet (10 mg) by mouth 1 time per day 90 
benazepril (LOTENSIN) 40 mg tablet Take 1 tablet (40 mg) by mouth 1 time per day 
Multiple Vitamins-Minerals (ZINC PO) Take 1 tablet by mouth 1 time per day 
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blood glucose test strip (ONETOUCH VERIO) 1 Strip 1 time per day 
Lancets (ONETOUCH DELICA) 1 each 1 time per day 100 
Specialty Vitamins Products (ECHINACEA C COMPLETE PO) Take 1 tablet by mouth 1 time 
per day 
CINNAMON PO Take 1 capsule by mouth 1 time per day 
 
Medical History  
 
Primary osteoarthritis of both knees 
Controlled type 2 diabetes mellitus without complication, without long-term current use of 
insulin (HCC) 
CKD (chronic kidney disease), stage III (HCC) 
Hypercholesterolemia 
Essential hypertension 
Neuroma of foot 
Obstructive sleep apnea of adult 
Severe obesity (HCC) 
 
Past Surgical History 
JOINT REPLACEMENT TOTAL KNEE Left 5/8/2019 
 
Family History 
Father – emphysema (deceased) 
Mother – Type 2 diabetes (living) 
Brother – no known history (living) 
 
ROS 
Constitutional: negative for fever, chills, unexpected weight loss or gain. Denies any recent 
illness. 
Cardiovascular: Denies chest pain, shortness of breath, palpitations, or leg swelling.  
Respiratory: Denies cough, shortness of breath, or wheezing. Reports she does have obstructive 
sleep apnea but does not use the CPAP machine as she does not like it.  
Gastrointestinal: Negative for nausea, vomiting, diarrhea or constipation. States her bowel 
pattern is regular about every day.  
Orthopedic: Arthralgias of right knee, mainly with movement. Reports grinding sensation.  
 
 
Physical / Results  
BP 136/90 Pulse 88 Temp 97 degrees F (36.1 degrees C) (Temporal) Wt. 168.3kg (371lb) SpO2 
98% BMI 53.23 (morbidly obese) 
Constitutional: Is alert and oriented x 4.  
Cardiovascular: Regular rate and rhythm, S1 and S2 audible. No murmur, click, rub or gallop 
audible.  
Respiratory: Lungs are clear bilaterally. No wheezing, stridor, rhonchi or rales are heard. Chest 
expansion is symmetrical. No cough heard. 
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Gastrointestinal: Abdomen is obese and rounded. No distension noted. Bowel sounds are 
normoactive. Abdomen is soft, no tenderness or guarding. No masses palpated.  
Extremities: peripheral pulses normal, no pedal edema, no clubbing or cyanosis. Some pain with 
flexion and extension of right knee. No deformity or edema noted. Crepitus present with 
movement of right knee.  
 
EKG: Normal sinus rhythm with heart rate in the 80’s.  
 
Imaging (Xray right knee 2 views): Moderately severe patellofemoral degenerative change. 
There is marked narrowing of the patellofemoral joint space laterally, with lateral deviation of 
the patella. Bulky peripheral osteophyte formation. No acute fracture or dislocation. 
 
Labs (CBC, CMP, A1C): Glucose 229mg/dL, BUN 21mg/dL, Creatinine 1.57mg/dL, GFR 






A search of the literature was done through the University of North Dakota’s Harley 
French library in the CINAHL online database. The search was conducted using the phrases 
“arthroplasty A1C” and “Total knee A1C”. This yielded a total of 166 articles: 91 for 
“arthroplasty A1C” and 75 for “Total knee A1C”. Of the 166 articles, ten articles were chosen 
due to the specificity of their content. A total of 10 articles will be used to review what an 
optimal HbA1C is and how blood glucose can affect outcomes intraoperatively and 
postoperatively.  
Optimal HbA1C 
 Hemoglobin A1C is a laboratory measurement of the patient’s glycemic status over the 
past 3-month period and is a good indicator of overall glycemic control. Typically, patients with 
diabetes have a regular scheduled follow up with their primary care provider to have their 
HbA1C checked. Ideally this occurs around every 3-6 months for most diabetic patients and is 
done in order to try to optimize their blood glucose management. The following paragraphs will 
discuss/summarize the findings of each article in relation to optimal HbA1C.  
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According to Yang et al. (2017) “Some studies have recommended that an HbA1c level 
of less than 7% could decrease the risk of systemic complications. Therefore, an HbA1C level of 
7% has been considered the cutoff for glycemic control in previous studies.” (p. 5). In the 
conclusion of this article the authors state their research indicates an elevated HbA1C and 
intraoperative hyperglycemia increase the risk for periprosthetic joint infections following the 
joint replacement. In contrast, an article published in International Orthopedics by Joseph Statz, 
Eric Wagner, John Sperling, and Robert Cofield, the authors performed a retrospective review of 
their institution’s joint registry to assess the relationship between HbA1C in patients with 
diabetes mellitus (DM) and outcomes related to shoulder arthroplasty (SA). In the conclusion of 
their review, Statz et al. (2018) report “Our findings in this study show that HbA1C is not a 
predictor of adverse outcomes in patients with DM undergoing SA.” (p. 1933). Although the 
authors concluded that HbA1C was not a predictor of adverse outcomes, it is recommended to 
attempt to optimize HbA1C prior to surgery. Although they recommend optimizing the HbA1C 
prior to surgery, the authors do not have an ideal HbA1C that is considered the cutoff value.  
To provide reference for an acceptable HbA1C level, an article written by Jennifer 
Abbasi in the Journal of the American Medical Association discussed what is considered the 
optimal HbA1C in patients with type 2 diabetes. The article considered patients with type 2 
diabetes overall and not just those in the preoperative setting who were planning on having a 
surgical procedure done. In the article, the American College of Physicians recommends a 
HbA1C goal of 7%-8% for most patients with type 2 diabetes. This contrasts with the 
recommendations set forth by the American Diabetes Association (ADA) and the American 
Association of Clinical Endocrinologists (AACE). The ADA recommends a HbA1C goal of less 
than 7% in general and the AACE recommends a HbA1C goal of 6.5% or less. This can be 
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confusing to patients and clinicians and therefore recommends that HbA1C goal should be 
discussed and agreed upon by both the patient and clinician in a personalized way.  
Postoperative Setting 
In an article written by Dr. Jourdan Cancienne, Dr. Brian Werner, and Dr. James Browne 
in 2017, the authors conducted original research by querying a patient records database for 
orthopedic cases and comparing HbA1C level to postoperative periprosthetic joint infections. In 
the review of the orthopedic cases, Cancienne, Werner and Browne (2017) report “We believe 
that although an HbA1c level greater than 8.0 mg/dL is helpful and should be referenced when 
stratifying a patient’s infection risk, it must be interpreted in the context of the patient’s other 
risk factors for PJI.” (p. 1648).  Further research is needed regarding factors other than HbA1C 
and how they influence postoperative periprosthetic infections. Further research may lead to 
better screening tools or guidelines to predict postoperative complications. In support of the 
American College of Physicians an article written in the Annals of Internal Medicine by Dr. 
Gerald Smetana, Dr. David Nathan, Dr. David Dugdale, and Dr. Risa Burns and is written in a 
case study format that asks the readers to decide how aggressive to be in treatment of a patients 
HbA1c based on available guidelines by the American College of Physicians. The authors of this 
article concur with the recommendations set for by the ACP by treating most patients to a HbA1c 
level between 7%-8%. They did not discuss the HbA1C specifically in relation to optimization 
preoperatively.  
In contrast, an article written by Dr. Steven DeFroda, Dr. Me Lee, and Dr. Derek Jenkins 
in 2016 utilized a retrospective pilot review over 3 months using a risk reduction strategy. This 
risk reduction strategy included smoking cessation, reduction in weight/BMI, and reduction in 
HbA1c. In this article, Defroda, Lee and Jenkins (2016) report that a HbA1c >7% led to an 
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increased risk of postoperative infection and that a specific study that focused on total knee 
arthoplastys found that a HbA1c >8% increased risk of surgical site infection. This information 
leads readers to believe any HbA1c level >7% would put patients at increased risk for 
postoperative complications.  
Blood Glucose Related Outcomes 
The postoperative complications in patients with diabetes can increase overall healthcare 
costs, extend hospital stays, and decrease quality of life. When discussing blood glucose related 
outcomes, an article written by Carey et al. (2018) utilized a retrospective cohort study that 
compared different types of infections between patients with type 1 diabetes and type 2 diabetes. 
This article didn’t specifically look at adverse outcomes in surgical patients but discussed overall 
complications seen in diabetic patients with elevated blood glucose levels. In the article, Carey et 
al. (2018) states “The association between diabetes and infection is well known clinically and 
has been linked to a number of casual pathways, including impaired immune responses within 
the hyperglycemic environment, as well as potentially other abnormalities associated with 
diabetes such as neuropathy and altered lipid metabolism.” (p. 513). This gives a basis to 
understand how elevated blood glucose levels in the pre, intra, and postoperative settings can 
adversely affect patients.  
Furthermore, Morrell, Dr. Gregory Golladay, and Dr. Stephen Kates conducted a 
retrospective review of 455 patients that underwent an elective total hip arthroplasty within their 
facility. They followed up 1 year after the procedure to assess complications such as 
periprosthetic joint infection. When discussing the risk of postoperative infection, Morrell, 
Golladay, and Kates (2018) state “Potential risk factors include poorly controlled diabetes 
(glucose >200 mg/L or HbA1c >7%) …” (p. 523). Therefore, if a patient’s blood glucose is kept 
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below 200 mg/L or their HbA1c was kept <7% they were less likely to have complications such 
as periprosthetic joint infections.  
Additional Glycemic Markers 
There are several lab tests available for the clinician to use when assessing glycemic 
control. Hwang et al (2015) discussed whether different glycemic markers such as HbA1c, 
fasting blood glucose and postprandial blood glucose would potentially cause complications in 
diabetic patients undergoing total knee arthroplasty. Hwang et al (2015) found “a positive 
correlation among the various available glycemic markers in patients undergoing TKA, and 
HbA1c > 8 or FBG > 200 mg/dL was associated with superficial surgical site infection” (p. 
1731). It is suggested that these values are the safe cutoff range for diabetic patients undergoing 
total knee arthroplasty. These values are not a guarantee that the patient will not have a surgical 
site infection or other complication after surgery but are the cutoff range at which values higher 
than these are when increased postoperative infections are seen. An article written by Dr. Gerold 
Labek looked at the study mentioned above that was written by Hwang et al. In this article, Dr. 
Labek discussed several questions that need to be asked in order to promote better outcomes. 
Some examples of questions asked in the article include: What other factors are associated with 
controlling blood glucose levels? What are modifiable patient or provider factors that are 
associated with blood glucose levels? Can providers prevent the complications such as infections 
by using specific implants with antibiotic coatings? If we were to apply these questions to Irene 
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Learning Points 
Several “key” learning points can be summarized from this review. These are included 
below in the following bullet points and could be used as a guide if questioning optimal HbA1c 
or fasting blood glucose prior to an arthroplasty procedure.  
• The optimal HbA1c to decrease the risk of complications is <7%. 
• The optimal fasting blood glucose level to decrease the risk of complications is 
<200 mg/dL preoperatively. 
• A HbA1c of < 8% may be acceptable in some patients after a personalized 
decision is made between patient and provider.  
Conclusion 
In this review, a patient with severe osteoarthritis in both knees is planning to have a total 
knee arthroplasty done on the right knee. Comorbidities include uncontrolled type 2 diabetes 
with poor medication compliance This is evidenced by the fasting blood glucose level of 229 
mg/dL and HbA1C of 7.9%.  
A review of the current literature was performed through UND’s Harley French library 
using the CINAHL database while searching for the optimal preoperative HbA1c and blood 
glucose levels. Based on a synthesis of the articles reviewed, it can be concluded that patients are 
at an increased risk of postoperative complications if their HbA1c level is above 7% or if their 
fasting blood glucose preoperatively is greater than 200 mg/dL. Based on these conclusions, and 
the recommendations from the ADA, the patient in this review would be considered at an 
increased risk for postoperative complications. It’s imperative that patient and provider 
understand the importance of adequate blood glucose management not only in the preoperative 
setting, but at all times to ensure the best possible outcomes. Primary care providers are in an 
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optimal position to diagnose, provide adequate treatment, strict follow up and education for 
patients with diabetes.  This will promote active involvement with the PCP and the patient to 
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